-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on CG Oncology, Raises Price Target to $66

Benzinga·01/12/2026 16:31:53
Listen to the news
Truist Securities analyst Gregory Renza maintains CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $62 to $66.